200 related articles for article (PubMed ID: 27797380)
21. Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma.
Chang TS; Chen CL; Wu YC; Liu JJ; Kuo YC; Lee KF; Lin SY; Lin SE; Tung SY; Kuo LM; Tsai YH; Huang YH
PLoS One; 2016; 11(2):e0149897. PubMed ID: 26919045
[TBL] [Abstract][Full Text] [Related]
22. Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, Atiprimod.
Choudhari SR; Khan MA; Harris G; Picker D; Jacob GS; Block T; Shailubhai K
Mol Cancer Ther; 2007 Jan; 6(1):112-21. PubMed ID: 17237271
[TBL] [Abstract][Full Text] [Related]
23. Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers.
Oikawa T; Kamiya A; Zeniya M; Chikada H; Hyuck AD; Yamazaki Y; Wauthier E; Tajiri H; Miller LD; Wang XW; Reid LM; Nakauchi H
Hepatology; 2013 Apr; 57(4):1469-83. PubMed ID: 23175232
[TBL] [Abstract][Full Text] [Related]
24. Replicative activity of hepatitis B virus is negatively associated with methylation of covalently closed circular DNA in advanced hepatitis B virus infection.
Kim JW; Lee SH; Park YS; Hwang JH; Jeong SH; Kim N; Lee DH
Intervirology; 2011; 54(6):316-25. PubMed ID: 21242658
[TBL] [Abstract][Full Text] [Related]
25. Differences in antiproliferative effect of STAT3 inhibition in HCC cells with versus without HBV expression.
Hong Y; Zhou L; Xie H; Wang W; Zheng S
Biochem Biophys Res Commun; 2015 Jun; 461(3):513-8. PubMed ID: 25899746
[TBL] [Abstract][Full Text] [Related]
26. Ku80 negatively regulates the expression of OCT4 via competitive binding to SALL4 and promoting lysosomal degradation of OCT4.
Zhao B; Zheng X; Tan X; Ke K; Wang F; Wang Y; Xing X; Zhang C; Hu P; Lan S; Li Q; Huang A; Liu X
Int J Biochem Cell Biol; 2020 Jan; 118():105664. PubMed ID: 31816404
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive DNA methylation analysis of hepatitis B virus genome in infected liver tissues.
Jain S; Chang TT; Chen S; Boldbaatar B; Clemens A; Lin SY; Yan R; Hu CT; Guo H; Block TM; Song W; Su YH
Sci Rep; 2015 May; 5():10478. PubMed ID: 26000761
[TBL] [Abstract][Full Text] [Related]
28. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
[TBL] [Abstract][Full Text] [Related]
29. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
30. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
[TBL] [Abstract][Full Text] [Related]
31. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
[TBL] [Abstract][Full Text] [Related]
33. EpCAM-regulated intramembrane proteolysis induces a cancer stem cell-like gene signature in hepatitis B virus-infected hepatocytes.
Mani SK; Zhang H; Diab A; Pascuzzi PE; Lefrançois L; Fares N; Bancel B; Merle P; Andrisani O
J Hepatol; 2016 Nov; 65(5):888-898. PubMed ID: 27238755
[TBL] [Abstract][Full Text] [Related]
34. lncRNA HAND2-AS1 overexpression inhibits cancer cell proliferation in hepatocellular carcinoma by downregulating RUNX2 expression.
Jing GY; Zheng XZ; Ji XX
J Clin Lab Anal; 2021 Apr; 35(4):e23717. PubMed ID: 33566427
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation.
Qiu X; Zhang L; Lu S; Song Y; Lao Y; Hu J; Fan H
Oncol Rep; 2014 Jan; 31(1):202-8. PubMed ID: 24247422
[TBL] [Abstract][Full Text] [Related]
36. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
37. IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B.
Lin SJ; Shu PY; Chang C; Ng AK; Hu CP
J Immunol; 2003 Nov; 171(9):4708-16. PubMed ID: 14568946
[TBL] [Abstract][Full Text] [Related]
38. LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer.
Feng J; Yang G; Liu Y; Gao Y; Zhao M; Bu Y; Yuan H; Yuan Y; Yun H; Sun M; Gao H; Zhang S; Liu Z; Yin M; Song X; Miao Z; Lin Z; Zhang X
Theranostics; 2019; 9(18):5227-5245. PubMed ID: 31410212
[No Abstract] [Full Text] [Related]
39. Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53.
Cao P; Yang A; Wang R; Xia X; Zhai Y; Li Y; Yang F; Cui Y; Xie W; Liu Y; Liu T; Jia W; Jiang Z; Li Z; Han Y; Gao C; Song Q; Xie B; Zhang L; Zhang H; Zhang J; Shen X; Yuan Y; Yu F; Wang Y; Xu J; Ma Y; Mo Z; Yu W; He F; Zhou G
Gastroenterology; 2018 Aug; 155(2):542-556. PubMed ID: 29702115
[TBL] [Abstract][Full Text] [Related]
40. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
